Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on the deal.Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascular disease with…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
